Twist Bioscience Corporation (TWST) Q4 2026 earnings results
Twist Bioscience Corporation (TWST) reported Q4 2026 results on Nov 12, 2026, 7:19:55 AM ET: GAAP EPS -$0.32 vs. -$0.20 expected (miss by 57.6%); revenue $126.64M vs. $123.63M expected (beat by 2.4%), according to Nexqual's capture of the SEC 8-K filing (nexqual.com/earnings/2026-11-12/TWST). Outlook: Fiscal 2027 revenue is expected to be $550 million to $560 million, with Q1 2027 revenue expected to be $130 million to $132 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$0.32 | -$0.20 | Miss by 57.6% |
| Revenue | $126.64M | $123.63M | Beat by 2.4% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 12, 2026, 7:19:55 AM ET. Nexqual published them 32 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 27.9% from $99.01M.
Stock reaction
The results came out before the market opened. TWST closed at $114.22 on November 12, 2026, down 6.8% from its $122.59 close on November 11, 2026 before the results. Latest: $116.50 as of 3:53 PM ET, −5.0% since the pre-release close.
Questions and answers
Did Twist Bioscience Corporation beat earnings expectations?
No. Twist Bioscience Corporation reported GAAP EPS of -$0.32 against an average analyst estimate of -$0.20 (miss by 57.6%), and revenue of $126.64M against $123.63M expected (beat by 2.4%). Source: Nexqual (nexqual.com/earnings/2026-11-12/TWST).
What were Twist Bioscience Corporation's Q4 2026 earnings and revenue?
GAAP diluted EPS of -$0.32 and revenue of $126.64M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 27.9% from $99.01M. Source: Nexqual (nexqual.com/earnings/2026-11-12/TWST).
When did Twist Bioscience Corporation report Q4 2026 earnings?
Nov 12, 2026, 7:19:55 AM ET, in an SEC 8-K filing (Item 2.02). Source: Nexqual (nexqual.com/earnings/2026-11-12/TWST).
How did TWST stock react to the earnings?
The results came out before the market opened. TWST closed at $114.22 on November 12, 2026, down 6.8% from its $122.59 close on November 11, 2026 before the results. Latest: $116.50 as of 3:53 PM ET, −5.0% since the pre-release close. Source: Nexqual (nexqual.com/earnings/2026-11-12/TWST).
What did Twist Bioscience Corporation say about its outlook?
Fiscal 2027 revenue is expected to be $550 million to $560 million, with Q1 2027 revenue expected to be $130 million to $132 million. Source: Nexqual (nexqual.com/earnings/2026-11-12/TWST).
More on TWST
TWST stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 12, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 18, 2026 at 20:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt